Pelvic Organ Prolapse

Earn CME/CE in your profession:


Continuing Education Activity

Pelvic organ prolapse (POP) is a gynecological condition in which the pelvic organs herniate into the vagina due to ligament or muscular weakness. POP is subcategorized according to the compartment of descent. Cystocele characterizes anterior wall herniation, rectocele refers to the posterior vaginal wall descent, and vaginal vault prolapse characterizes descent of the uterus, cervix, or apex of the vagina. This activity illustrates the evaluation and management of pelvic organ prolapse and highlights the role of the interprofessional team in the care of patients with this condition.

Objectives:

  • Identify the etiology of pelvic organ prolapse.
  • Review the evaluation of pelvic organ prolapse.
  • Outline the management options available for pelvic organ prolapse.

Introduction

Pelvic organ prolapse is the descent of pelvic structures into the vagina due to ligament or muscular weakness. Pelvic organ prolapse (POP) is subcategorized according to the compartment of descent. Cystocele characterizes anterior wall herniation, rectocele refers to the posterior vaginal wall descent, and vaginal vault prolapse characterizes descent of the uterus, cervix, or apex of the vagina. They can occur either singly or in combination. Although the etiology of POP is multifactorial, there is a high correlation with pregnancy and vaginal delivery, which can lead to direct pelvic floor muscle and connective tissue injury.[1] 

Additionally, prior pelvic surgeries or conditions associated with sustained episodes of increased intrabdominal pressure such as heavy lifting, obesity, chronic cough, and constipation can increase the risk of developing POP. Most patients who present with prolapse are asymptomatic. However, symptoms become more bothersome as the bulge protrudes past the vaginal opening. Initial evaluation includes a detailed history and a systematic pelvic exam. An assessment of POP complications, including urinary incontinence, bladder outlet obstruction, and fecal incontinence, must be made.[2] 

Treatment options vary and are dependent upon the degree of prolapse and symptoms. Treatments include simple observation, vaginal pessaries, or surgical management. Available surgical options are reconstructive pelvic surgery with or without mesh augmentation and obliterative surgery.

Etiology

DeLancey demonstrated that normal pelvic support is provided by the interaction between the levator ani muscle group and connective tissue attachments that stabilize the vagina at varying levels. Any weakness or tears within the connective tissue leads to the varying pathology of pelvic floor defects.[3] 

With normal pelvic support, the vagina lies horizontally on top of the levator ani muscles. Damage causes the levator ani muscles to become more vertical in orientation, opening the vagina, and thus shifting support to the connective tissue attachments.[4] Through biomechanical modeling, it was postulated that the second stage of labor causes the levator ani muscles to stretch more than 200% beyond the threshold for injury.[5] 

Pelvic organ prolapse (POP) is a common condition that is multifactorial in etiology.[6] Combinations of anatomical, physiological, genetic, lifestyle, and reproductive factors interact throughout a woman’s lifespan to contribute to pelvic floor dysfunction. Many studies have correlated parity with a high incidence of POP.[7]

Epidemiology

The incidence of pelvic organ prolapse is highly associated with increased age.[8] Many women with symptomatic POP suffer physical and emotional distress leading to a negative impact on a women’s social, physical, and psychological well-being. Although the exact prevalence of pelvic organ prolapse is unknown, an analysis of hospital procedure codes reveals that approximately 200,000 surgeries for POP treatment are performed annually in the United States.[9] 

Although about 41% to 50% of women present with POP on physical examination, only about 3% are symptomatic.[10] The incidence of pelvic organ prolapse is projected to increase by 46%, to 4.9 million, by 2050.[11]

History and Physical

The majority of patients who present with pelvic organ prolapse do not report symptoms. Patients that do present with symptoms, however, often describe a sense or feeling of a bulge protruding through the vaginal opening. During yearly well-woman visits, it is essential to screen women for urinary and bulge symptoms that a woman often is embarrassed to bring up during her annual.[12] 

A physical examination is essential to diagnose and subcategorize the type of prolapse. Exam findings will vary depending on the fullness of both the bladder and rectum. Women who present with procidentia (prolapse of all 3 compartments) can complain of vaginal discharge secondary to vaginal chafing or epithelial erosion. Patients with POP have a high rate of coexisting pelvic floor disorders. 40% will present with urinary incontinence, 37% will present with overactive bladder, and 50% will present with fecal incontinence.[13] Patients should be routinely screened for alternative pathologies. In many cases, prolapse can mask a hidden stress urinary incontinence.[14] 

Due to urethral kinking or urethral pressure, bladder outlet obstruction can occur. Pelvic organ prolapse may negatively affect sexual activity, body image, and quality of life. Clinicians should always remember to screen for POP as many patients will not openly admit to symptoms out of embarrassment. A systematic pelvic examination is required to fully characterize the type and extent of prolapse. Begin by asking the patient to perform the Valsalva maneuver and inspect the perineal body, vaginal opening, and screen for apical prolapse. Next, a speculum is inserted in order to better visualize the vaginal apex. Using a one-blade sims speculum, the anterior and posterior vaginal walls can be inspected to assess for the presence of cystocele and rectocele, respectively. Either the Baden-Walker grading system or the pelvic organ prolapse quantification system can be used to quantify the degree of prolapse and can be an aid clinical assessment.[15]

Evaluation

When considering the diagnosis of POP, assessment for infection, hematuria, and incomplete bladder emptying are necessary. If the patient has significant voiding symptoms, a urodynamic evaluation is recommended to assess bladder and sphincteric function.[16] 

Detrusor dysfunction with high post-void residual is a common problem in patients with severe prolapse. Reduction of the prolapse during the urodynamic evaluation will help to properly assess sphincteric function and unmask stress urinary incontinence by unkinking the urethra, which is commonly associated with severe prolapse that would have been otherwise missed. Imaging of the kidney and the ureter by computed tomography (CT) urogram is indicated in women with severe procidentia as the pelvic anatomy, especially the right ureter, might be distorted by the descent of the bladder, pulling down on the ureters, causing obstruction and hydronephrosis.[17]

Treatment / Management

Both conservative and surgical management may be appropriate depending on patient age, desire for future fertility and coital function, symptoms severity, and concomitant medical problems. Treatment is additionally dictated by the compartment of descent. Goals of management include symptomatic relief, maintenance or improvement of sexual function, prevention of new support defects and incontinence, and restoration of adequate pelvic support.[18]

In women with mild, asymptomatic cases, observation and close follow-up are appropriate. Most women do not experience symptoms until the bulge protrudes past the vaginal opening. Pelvic floor muscle training exercise (Kegel exercises) allows a systematic contraction of the levator ani muscles strengthening the pelvic floor. Kegel exercises have been proven to improve symptoms of stress urge and mixed incontinence and can be useful in women with mild POP.[19]

Two-thirds of patients with symptomatic POP choose management with a pessary, and up to 77% will continue use after one year.[20] Pessaries are devices, often made of medical-grade silicone, that are positioned in the vagina to restore normal pelvic anatomy. They are an option for all stages of prolapse and are useful to prevent the progression of prolapse and can delay the need for surgery. 85% of patients are successfully fit for a pessary.[21] However, patients with short vaginal length, wide vaginal opening, or a history of hysterectomy can often have a fitting failure. Often, the initial pessary of choice is a ring pessary that is folded in half for insertion and fits between the pubic symphysis and posterior vaginal fornix. A successful pessary fit remains in place more than one fingerbreadth above the introitus when the patient bears down. After fitting, the patient should sit, walk, and void to ensure comfort and urinary retention. Patients should be instructed that removal and cleaning are necessary nightly, weekly, biweekly, or monthly.  

When considering surgical intervention for pelvic organ prolapse, patient goals for future fertility goals and expectations must be considered and discussed. A variety of procedures, both abdominal and vaginal, are performed in an attempt to restore the pelvic floor function and relieve symptoms. The procedure with an anatomic success rate of 98% and a subjective success rate of 93% is an obliterative procedure known as colpoclesis in which the vaginal cuff is shortened.[22] However, before performing this reconstructive procedure, it is imperative to counsel the patient that coital function is no longer feasible. For patients who wish to maintain coital function, various reconstructive surgeries can be considered.

Adequate support of the vaginal apex has been recognized as an essential component of an adequate surgical repair for advanced prolapse. While some approaches focus on women's native tissues and ligaments for suspension, many incorporate biological grafts or mesh. The advantages of transvaginal approaches include shorter operative and recovery times, whereas the advantages of abdominal approaches provide more durable outcomes and decrease the risk of recurrence.[23]

One of the most widely performed transvaginal suspension procedures is the sacrospinous fixation in which the coccygeus sacrospinous ligament is attached to the vaginal apex. Advantages include avoiding the morbidity of an abdominal incision, achieving a functional vagina, and the ability to repair coexisting anterior and posterior compartment defects using a single surgical site.[24]  However, because the technique displaces the vaginal axis posteriorly, it can often lead to the development of new anterior compartment defects.[25] Associated complications that have been reported include intraoperative hemorrhage due to laceration of the pudendal artery, vaginal shortening, sexual dysfunction, and injury to the pudendal nerve.[26]

Another transvaginal approach with an excellent success rate of apical support is the iliococcygeus suspension. This transvaginal procedure attaches the vaginal apex to the fascia of the iliococcygeus muscle.[27] Since the vaginal axis is unaffected, an anterior compartment prolapse is very rare. Vaginal shortening is a major complication since the ischial spines are inferior to the normal position of the vaginal apex.

The uterosacral suspension is an alternative transvaginal approach in which the plication of the uterosacral ligaments across the midline is preformed and attached to the vaginal cuff. Disadvantages to consider in this approach is the proximity of the uterosacral ligaments to the ureters.[23]

In recent years, the procedure of choice has become the abdominal sacrocolpopexy, which can be done by either laparotomy, laparoscopy, or robotic-assisted. Since the initial delineation of the procedure by Lane in 1962, the procedure has gone through many modifications. Birnbaum has advocated anchoring the suspensory mesh to the sacrum. However, there is a high risk of hemorrhage from laceration of the presacral vessels.[28] 

Varying suspensory materials have been used, including mesh, non-absorbable suture, fascia, and dura mater. It is generally believed now that abdominal sacrocolpopexy with mesh provides long-term relief of pelvic prolapse symptoms and restores vaginal function.[29] This procedure should be considered as the primary approach in women who want to retain vaginal function as well as those who have failed previous operations to treat uterine and vaginal vault prolapse.

Differential Diagnosis

Although pelvic organ prolapse may seem relatively unique in its clinical depiction, there have been instances when POP has been misdiagnosed with alternative pathologies. Considerations when observing bulge symptoms during an office visit include vaginal cysts, cervical polyps, elongation of the cervix, tumors of the urethra or bladder, large urethral diverticulum, and skene gland cysts.

Staging

Both the American Urogynecologic Society and the Society of Gynecologic Surgeons agreed upon a consensus document for staging pelvic organ prolapse at the 1996 International Continence Society.[30] The resulting pelvic organ prolapse quantification system (POP-Q) has been widely utilized in both clinical practice and research.[31] 

The technique measures compartment prolapse relative to the anatomic landmark of the hymen. Prolapse points proximal to the hymen are given a negative value, whereas positive values are given to points that protrude past the hymen. 6 points are delineated, including two on the anterior vaginal wall (Aa, Ba), two on the vaginal apex (C, D), and two on the posterior vaginal wall (Ap, Bp). Points Gh, Pb, and TVL describe the genital hiatus, perineal body, and total vaginal length, respectively.[32] 

Previously used, the Baden-Walker Halfway system is an alternative grading system for pelvic organ prolapse.[15] Normal pelvic support is defined as grade 0. Descent half the distance to the hymen is grade 1, distant at the hymen is grade 2, and distant distal to the hymen is grade 3. Stage 4 describes complete procidentia.

Prognosis

Although bothersome, pelvic organ prolapse has a non-life-threatening prognosis. Most patients are asymptomatic to start. Those that have bulge symptoms have a high rate of regression with pessaries and non-invasive treatments. Surgical intervention has a 95% success rate, and studies analyzing the 2-year and 5-year follow-up and patient satisfaction have shown marked improvement in bulge symptoms and minimal new morbidities.[33]

Complications

Concomitant urinary symptoms may be complicated by pelvic organ prolapse. Thus, when working up a patient for POP, it is essential to retract the bulge and assess for signs of urinary incontinence that have been masked by prolapse.[14] Additionally, fecal incontinence and obstruction can be a significant complication of POP. Many patients can describe the splinting in which a finger in the vagina is required to aid in defecation.[13]

Although treatment with a pessary has an impressive success rate, there are a number of complications patients should be informed about prior to placement. If the patient presents to follow up with vaginal discharge, irritation, ulceration, bleeding pain and odor, vaginal wall ulceration, fistula formation, or bowel herniation, pessary complications should be suspected.[34] Infection with anaerobes such as bacterial vaginosis has a high occurrence in women who change their pessaries less than once per week.[35] Vaginal ulceration and bleeding occur more commonly in postmenopausal women and with less frequent pessary removal.  

Many complications in the treatment of POP have been associated with mesh insertion. The use of transvaginal mesh and biological graft material in prolapse surgery is controversial and has led to a number of inquiries into their safety and efficacy. Recently, the FDA has abandoned the use of large mesh grafts in the vagina in the correction of pelvic organ prolapse, and vaginal repair is limited to the use of either native tissue or a biological graft.[36] High-risk mesh-related complications include infection and dyspareunia. Mesh with a pore size <10 micrometers allows bacterial, but not macrophage infiltration, and can lead to high rates of infection.[37]

Deterrence and Patient Education

Educating patients on the high incidence of pelvic organ prolapse can deter associated stigmas and psychosocial factors that delay diagnosis. Both the International Urogynecology Association (IUGA) and the American Urogynecologic Society (AUGS) have provided education pamphlets and printable information that can explain symptoms expected workup, and treatment options. Education pamphlets explaining home maintenance and self-care of pessaries have significantly reduced pessary complications and have increased patient confidence in treatment.[38]

Enhancing Healthcare Team Outcomes

Often, low-grade pelvic organ prolapse can easily be managed by a single general obstetrics and gynecology provider. More advanced cases may require referral to a urogynecologist for more aggressive intervention. Pelvic organ prolapse associated with comorbid disorders, including stress urinary incontinence, fecal incontinence, defecatory dysfunction, or alternative abnormalities in the lower urinary tract, may benefit from an interprofessional team as depicted by the National Institute for Health and Clinical Excellence (NICE).[39] This team is comprised of a urogynecologist, urologist, specialist nurse, a physiotherapist, and a colorectal surgeon. This approach can standardize treatments in more complicated cases of pelvic organ prolapse.


Details

Editor:

Paul Liu

Updated:

10/3/2022 8:44:47 PM

References


[1]

Vergeldt TF,Weemhoff M,IntHout J,Kluivers KB, Risk factors for pelvic organ prolapse and its recurrence: a systematic review. International urogynecology journal. 2015 Nov;     [PubMed PMID: 25966804]

Level 1 (high-level) evidence

[2]

Iglesia CB,Smithling KR, Pelvic Organ Prolapse. American family physician. 2017 Aug 1;     [PubMed PMID: 28762694]


[3]

DeLancey JO, What's new in the functional anatomy of pelvic organ prolapse? Current opinion in obstetrics     [PubMed PMID: 27517338]

Level 3 (low-level) evidence

[4]

Rubod C,Lecomte-Grosbras P,Brieu M,Giraudet G,Betrouni N,Cosson M, 3D simulation of pelvic system numerical simulation for a better understanding of the contribution of the uterine ligaments. International urogynecology journal. 2013 Aug 20;     [PubMed PMID: 23958831]

Level 3 (low-level) evidence

[5]

Dietz HP,Simpson JM, Levator trauma is associated with pelvic organ prolapse. BJOG : an international journal of obstetrics and gynaecology. 2008 Jul;     [PubMed PMID: 18503571]


[6]

Schaffer JI,Wai CY,Boreham MK, Etiology of pelvic organ prolapse. Clinical obstetrics and gynecology. 2005 Sep;     [PubMed PMID: 16012231]


[7]

Yan W,Li X,Sun S,Xiang Y,Zhou Y,Zeng X,Xie F,Jiang H,Liu Q,Xiang J, [Risk factors for female pelvic organ prolapse and urinary incontinence]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. 2018 Dec 28;     [PubMed PMID: 30643051]


[8]

Chow D,Rodríguez LV, Epidemiology and prevalence of pelvic organ prolapse. Current opinion in urology. 2013 Jul;     [PubMed PMID: 23619578]

Level 3 (low-level) evidence

[9]

Thompson CD,Henderson BE,Stanley R, Bladder calculi causing irreducible urogenital prolapse. BMJ case reports. 2018 Sep 12;     [PubMed PMID: 30209144]

Level 3 (low-level) evidence

[10]

Doshani A,Teo RE,Mayne CJ,Tincello DG, Uterine prolapse. BMJ (Clinical research ed.). 2007 Oct 20;     [PubMed PMID: 17947787]


[11]

Wu JM,Hundley AF,Fulton RG,Myers ER, Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstetrics and gynecology. 2009 Dec;     [PubMed PMID: 19935030]


[12]

Hammad FT,Elbiss HM,Osman N, The degree of bother and healthcare seeking behaviour in women with symptoms of pelvic organ prolapse from a developing gulf country. BMC women's health. 2018 May 30;     [PubMed PMID: 29843703]


[13]

Karjalainen PK,Mattsson NK,Nieminen K,Tolppanen AM,Jalkanen JT, The relationship of defecation symptoms and posterior vaginal wall prolapse in women undergoing pelvic organ prolapse surgery. American journal of obstetrics and gynecology. 2019 Nov;     [PubMed PMID: 31128111]


[14]

Cortesse A,Cardot V,Basset V,Le Normand L,Donon L, [Treatment of Urinary incontinence associated with genital prolapse: Clinical practrice guidelines]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2016 Jul;     [PubMed PMID: 27595630]


[15]

Baden WF,Walker TA, Genesis of the vaginal profile: a correlated classification of vaginal relaxation. Clinical obstetrics and gynecology. 1972 Dec;     [PubMed PMID: 4649139]


[16]

Abdullah B,Nomura J,Moriyama S,Huang T,Tokiwa S,Togo M, Clinical and urodynamic assessment in patients with pelvic organ prolapse before and after laparoscopic sacrocolpopexy. International urogynecology journal. 2017 Oct;     [PubMed PMID: 28283710]


[17]

Costantini E,Lazzeri M,Mearini L,Zucchi A,Del Zingaro M,Porena M, Hydronephrosis and pelvic organ prolapse. Urology. 2009 Feb;     [PubMed PMID: 18950840]


[18]

Kapoor DS,Thakar R,Sultan AH,Oliver R, Conservative versus surgical management of prolapse: what dictates patient choice? International urogynecology journal and pelvic floor dysfunction. 2009 Oct;     [PubMed PMID: 19543676]


[19]

Li C,Gong Y,Wang B, The efficacy of pelvic floor muscle training for pelvic organ prolapse: a systematic review and meta-analysis. International urogynecology journal. 2016 Jul;     [PubMed PMID: 26407564]

Level 1 (high-level) evidence

[20]

Coolen AWM,Troost S,Mol BWJ,Roovers JPWR,Bongers MY, Primary treatment of pelvic organ prolapse: pessary use versus prolapse surgery. International urogynecology journal. 2018 Jan;     [PubMed PMID: 28600758]


[21]

Manonai J,Sarit-Apirak S,Udomsubpayakul U, Vaginal ring pessary use for pelvic organ prolapse: continuation rates and predictors of continued use. Menopause (New York, N.Y.). 2018 Dec 17;     [PubMed PMID: 30562318]


[22]

Deffieux X,Thubert T,Donon L,Hermieu JF,Le Normand L,Trichot C, [Colpocleisis: guidelines for clinical practice]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie. 2016 Jul;     [PubMed PMID: 27595627]


[23]

Jelovsek JE,Barber MD,Brubaker L,Norton P,Gantz M,Richter HE,Weidner A,Menefee S,Schaffer J,Pugh N,Meikle S, Effect of Uterosacral Ligament Suspension vs Sacrospinous Ligament Fixation With or Without Perioperative Behavioral Therapy for Pelvic Organ Vaginal Prolapse on Surgical Outcomes and Prolapse Symptoms at 5 Years in the OPTIMAL Randomized Clinical Trial. JAMA. 2018 Apr 17;     [PubMed PMID: 29677302]

Level 1 (high-level) evidence

[24]

Declas E,Giraudet G,Delplanque S,Rubod C,Cosson M, How we perform a posterior sacrospinous ligament fixation by the vaginal route. International urogynecology journal. 2020 Jul;     [PubMed PMID: 31813030]


[25]

Hu CD,Chen YS,Yi XF,Ding JX,Feng WW,Yao LQ,Huang J,Zhang Y,Hu WG,Zhu ZL,Hua KQ, [Comparison outcomes of three surgical procedures in treatment of severe pelvic organ prolapse and analysis of risk factors for genital prolapse recurrence]. Zhonghua fu chan ke za zhi. 2011 Feb;     [PubMed PMID: 21426765]


[26]

Pahwa AK,Arya LA,Andy UU, Management of arterial and venous hemorrhage during sacrospinous ligament fixation: cases and review of the literature. International urogynecology journal. 2016 Mar;     [PubMed PMID: 26282092]

Level 3 (low-level) evidence

[27]

Meeks GR,Washburne JF,McGehee RP,Wiser WL, Repair of vaginal vault prolapse by suspension of the vagina to iliococcygeus (prespinous) fascia. American journal of obstetrics and gynecology. 1994 Dec;     [PubMed PMID: 7802052]


[28]

Geltzeiler CB,Birnbaum EH,Silviera ML,Mutch MG,Vetter J,Wise PE,Hunt SR,Glasgow SC, Combined rectopexy and sacrocolpopexy is safe for correction of pelvic organ prolapse. International journal of colorectal disease. 2018 Oct;     [PubMed PMID: 30076441]


[29]

Barbalat Y,Tunuguntla HS, Surgery for pelvic organ prolapse: a historical perspective. Current urology reports. 2012 Jun;     [PubMed PMID: 22528116]

Level 3 (low-level) evidence

[30]

Hall AF,Theofrastous JP,Cundiff GW,Harris RL,Hamilton LF,Swift SE,Bump RC, Interobserver and intraobserver reliability of the proposed International Continence Society, Society of Gynecologic Surgeons, and American Urogynecologic Society pelvic organ prolapse classification system. American journal of obstetrics and gynecology. 1996 Dec;     [PubMed PMID: 8987926]


[31]

Madhu C,Swift S,Moloney-Geany S,Drake MJ, How to use the Pelvic Organ Prolapse Quantification (POP-Q) system? Neurourology and urodynamics. 2018 Aug;     [PubMed PMID: 30614056]


[32]

Harmanli O, POP-Q 2.0: its time has come! International urogynecology journal. 2014 Apr;     [PubMed PMID: 24504063]


[33]

Hugele F,Panel L,Farache C,Kashef A,Cornille A,Courtieu C, Two years follow up of 270 patients treated by transvaginal mesh for anterior and/or apical prolapse. European journal of obstetrics, gynecology, and reproductive biology. 2017 Jan;     [PubMed PMID: 27886523]


[34]

Al-Shaikh G, Syed S, Osman S, Bogis A, Al-Badr A. Pessary use in stress urinary incontinence: a review of advantages, complications, patient satisfaction, and quality of life. International journal of women's health. 2018:10():195-201. doi: 10.2147/IJWH.S152616. Epub 2018 Apr 17     [PubMed PMID: 29713205]

Level 2 (mid-level) evidence

[35]

Fregosi NJ,Hobson DTG,Kinman CL,Gaskins JT,Stewart JR,Meriwether KV, Changes in the Vaginal Microenvironment as Related to Frequency of Pessary Removal. Female pelvic medicine     [PubMed PMID: 29474292]


[36]

Fekete Z,Körösi S,Németh G, [Vaginal mesh operations in the urogynecological practice after the FDA warnings. Use or not to use mesh?] Orvosi hetilap. 2018 Mar;     [PubMed PMID: 29504419]

Level 2 (mid-level) evidence

[37]

Falagas ME,Velakoulis S,Iavazzo C,Athanasiou S, Mesh-related infections after pelvic organ prolapse repair surgery. European journal of obstetrics, gynecology, and reproductive biology. 2007 Oct;     [PubMed PMID: 17459563]


[38]

Murray C,Thomas E,Pollock W, Vaginal pessaries: can an educational brochure help patients to better understand their care? Journal of clinical nursing. 2017 Jan;     [PubMed PMID: 27239963]


[39]

Pandeva I,Biers S,Pradhan A,Verma V,Slack M,Thiruchelvam N, The impact of pelvic floor multidisciplinary team on patient management: the experience of a tertiary unit. Journal of multidisciplinary healthcare. 2019;     [PubMed PMID: 30936714]